Bioventus Exercises Call Option to Acquire CartiHeal
April 04, 2022 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., April 04, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it has exercised...
Bioventus to Present at the Canaccord Genuity Musculoskeletal Conference
March 16, 2022 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., March 16, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Ken Reali, chief executive officer, will...
Bioventus Reports Fourth Quarter and Full Year 2021 Financial Results; Introduces Full Year 2022 Financial Guidance
March 10, 2022 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., March 10, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...
Bioventus Receives 510(k) Clearance for StimRouter Pain Management Device
March 01, 2022 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., March 01, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced that the US Food and Drug...
Bioventus Appoints Mark Singleton as Chief Financial Officer
February 28, 2022 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it has appointed...
Bioventus to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 10, 2022
February 22, 2022 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
Bioventus Announces Preliminary Fourth Quarter and Full-Year 2021 Revenue
January 11, 2022 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today preliminary revenue...
Bioventus to Present at the 40th Annual J.P. Morgan Healthcare Conference
December 28, 2021 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Ken Reali, chief executive officer, will present...
Bioventus Appoints Michelle McMurry-Heath to Board of Directors
December 21, 2021 09:25 ET
|
Bioventus, Inc.
DURHAM, N.C., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has announced the appointment of...
Bioventus Receives US FDA Clearance for BoneScalpel® Access™
December 20, 2021 08:30 ET
|
Bioventus, Inc.
DURHAM, N.C., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced the US Food and Drug...